These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33211809)

  • 1. Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season.
    Izurieta HS; Lu M; Kelman J; Lu Y; Lindaas A; Loc J; Pratt D; Wei Y; Chillarige Y; Wernecke M; MaCurdy TE; Forshee R
    Clin Infect Dis; 2021 Dec; 73(11):e4251-e4259. PubMed ID: 33211809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
    Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
    Clin Infect Dis; 2021 Sep; 73(5):816-823. PubMed ID: 33605977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons.
    Levin MJ; Divino V; Postma MJ; Pelton SI; Zhou Z; DeKoven M; Mould-Quevedo J
    Expert Rev Vaccines; 2024; 23(1):124-136. PubMed ID: 38073493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2020 Jun; 222(2):278-287. PubMed ID: 32100009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Balasubramani GK; Choi WS; Nowalk MP; Zimmerman RK; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Jackson ML; Jackson LA; Chung JR; Spencer S; Fry AM; Patel M; Flannery B;
    Vaccine; 2020 Sep; 38(42):6562-6569. PubMed ID: 32800465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Lee JKH; Lam GKL; Shin T; Samson SI; Greenberg DP; Chit A
    Vaccine; 2021 Mar; 39 Suppl 1():A24-A35. PubMed ID: 33422382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.
    Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2018 Aug; 67(3):1-20. PubMed ID: 30141464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season.
    Imran M; Puig-Barbera J; Ortiz JR; Lopez-Gonzalez L; Dean A; Bonafede M; Haag MDM
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13288. PubMed ID: 38644564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza Season.
    Imran M; Puig-Barbera J; Ortiz JR; Fischer L; O'Brien D; Bonafede M; Mansi JA; Boikos C
    Open Forum Infect Dis; 2022 May; 9(5):ofac167. PubMed ID: 35493131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
    Gaglani M; Vasudevan A; Raiyani C; Murthy K; Chen W; Reis M; Belongia EA; McLean HQ; Jackson ML; Jackson LA; Zimmerman RK; Nowalk MP; Monto AS; Martin ET; Chung JR; Spencer S; Fry AM; Flannery B
    Clin Infect Dis; 2021 Apr; 72(7):1147-1157. PubMed ID: 32006430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
    Belongia EA; Levine MZ; Olaiya O; Gross FL; King JP; Flannery B; McLean HQ
    Vaccine; 2020 Mar; 38(15):3121-3128. PubMed ID: 32145994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications.
    Boikos C; Imran M; Nguyen VH; Ducruet T; Sylvester GC; Mansi JA
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018.
    Boikos C; Sylvester GC; Sampalis JS; Mansi JA
    Clin Infect Dis; 2020 Dec; 71(10):e665-e671. PubMed ID: 32253431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    van Aalst R; Gravenstein S; Mor V; Mahmud SM; Wilschut J; Postma M; Chit A
    Vaccine; 2020 Jan; 38(2):372-379. PubMed ID: 31606249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
    Lu Y; Chillarige Y; Izurieta HS; Wei Y; Xu W; Lu M; Sung HM; Lindaas A; Wernecke M; Macurdy T; Kelman J; Forshee RA
    J Infect Dis; 2019 Sep; 220(9):1511-1520. PubMed ID: 31290553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States.
    Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
    Clin Infect Dis; 2021 Aug; 73(3):e692-e698. PubMed ID: 33400775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
    Zimmerman RK; Patricia Nowalk M; Dauer K; Clarke L; Raviotta JM; Balasubramani GK
    Vaccine; 2023 Aug; 41(35):5134-5140. PubMed ID: 37474406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.
    Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Bresee JS; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2017 Aug; 66(2):1-20. PubMed ID: 28841201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.